Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines
NCT ID: NCT06141512
Last Updated: 2024-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
21 participants
INTERVENTIONAL
2023-10-23
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, only exercise training is a viable method for increasing V̇O2max. However, although exercise training on average improves V̇O2max, \~10-20% of people who follow fully supervised, standardised training interventions do not demonstrate a measurable increase in V̇O2max. Low response to training is a clinically relevant concern, but the large variability in response to exercise training also provides an opportunity to dissect out the molecular mechanisms responsible for adaptations to V̇O2max by contrasting low vs. high responders to training.
Using this approach it has previously been shown that in skeletal muscle samples obtained pre- and post- training, 86 genes are differentially regulated in high compared to low responders for V̇O2max. Strikingly, out of these 86 genes, 13 genes encode proteins that have been reported to be released by muscle during or after exercise (i.e., 'messenger proteins' termed myokines). This strongly suggests low responders to exercise training fail to sufficiently upregulate the production and release of these myokines, and that this is (at least partly) the reason why these people do not manage to improve their V̇O2max as much as high responders. However, in order to confirm a mechanistic role of these myokines in increasing V̇O2max, it needs to be demonstrated that beside the change in gene expression, the change in the plasma levels of these myokines is also impaired in low responders for V̇O2max.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reduced-exertion high-intensity interval training (REHIT)
All participants complete 6 weeks (3 sessions/week) of an exercise intervention labelled 'REHIT'.
Exercise sessions involve 10 minutes of unloaded cycling interspersed with 2 x 20 sec 'all-out' sprints against a resistance of 7.5% of participant's body weight. Sprints begin at 1:40 min and 5:40 min.
Reduced-exertion high-intensity interval training (REHIT)
Description same as Arm description.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reduced-exertion high-intensity interval training (REHIT)
Description same as Arm description.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 y or \<40 y
* BMI \< 35 kg/m2
* otherwise healthy, untrained individuals
Exclusion Criteria
* BMI \> 35 kg/m2
* classification of 'highly physically active' according to the International Physical Activity Questionnaire (IPAQ)
* answering 'yes' to one or more questions on a standard Physical Activity Readiness Questionnaire (PAR-Q)
* resting heart rate ≥100bpm, clinically significant hypertension (140/90 mmHg)
* a personal history of metabolic or cardiovascular disease
* Female participants because of unknown effects of the menstrual cycle on the levels of the measured myokines.
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Stirling
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Niels Vollaard
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Niels Vollaard, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Stirling
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Stirling
Stirling, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UStirling
Identifier Type: -
Identifier Source: org_study_id